ABL1: ABL proto-oncogene 1; CAD: coronary artery disease; CML: chronic myeloid leukemia; FGFR: fibroblast growth factor receptor PDGFR: platelet-derived growth factor receptor; VEGFR: vascular endothelial growth factor receptor; VTE: venous thromboembolism. This evidence concerns the gene ABL1 and venous thromboembolism.